Misti Ushio, Digitalis Ventures
“RNA is always great to work with. They’re smart, they work fast, and they can jump in and get up to speed quickly. When we had critical needs, they’ve been able to really help us out in tough spots.”
Due Diligence Support (Buy-Side): Fund Manager
Buy-Side Due Diligence Support for Life Sciences Investment Fund Manager
The Column Group
Chris White, Healthcare Royalty
“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
Supporting the Entire Life Cycle: Biotech Company
RNA Advisors Supported a Biotech Company from Inception through IPO through M&A
Gary Yeung, YK Bioventures
“RNA Advisors has been my go-to valuation firm for all the companies I have built. In my new capacity as a VC, I would recommend RNA Advisors to all my portfolio companies. RNA staff is one of the industry’s most capable and collaborative experts.”
Portfolio Valuation: Life Sciences Investments
Pension Plan Needs Life Sciences Investment Portfolio Valuation
M&A Valuation Support: Medical Device Company
Venture-backed Medical Device Company Needs to Assess Value From Different Perspectives
Commercial Assessment (Buy-Side): Therapeutic
Buy-Side Market Assessment and Forecast for a Commercial Therapeutic
